Yunpeng Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yunpeng Liu has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Chengshi Quan
The Key Laboratory of Pathobiology, Ministry of Education, Beyuthune Medical College, Jilin University, Changchun, Jilin, China
1 shared publication - Guoguang Shao
Department of Thoracic Surgery, The First Hospital of Jilin University, Changchun, 130021, PR China
1 shared publication - Liping Wang
Qiqihar Medical University
1 shared publication - Min Wang
Department of Pathology, Jilin Provincial Cancer Hospital, Changchun, Jiliin, China (mainland)
1 shared publication - Peipeng Cui
Second Hospital of Jilin University, Changchun, Jilin, 130041, China
1 shared publication - Peng Zhang
Department of Thoracic Surgery, First Hospital of Jilin University, Changchun, Jilin Province, 130021, PR of China
1 shared publication
Latest Publications
- Open Access
- 15 March 2013
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 8 (1) , 46
Right lower lobectomy eight years after left pneumonectomy for a second primary lung cancer
Lobectomy for second primary lung cancer in a patient with previous pneumonectomy is seldom done because most such patients either have inadequate pulmonary reserve or metastatic disease at other sites. This is different than when this type of surgery is done for benign disease where the lobe to be resected is already non functional. We report a case where successful right lower lobectomy for a second primary lung cancer was carried out in a 53 year old man who had had a left pneumonectomy eight years before. We conclude that, although this type of approach can be worthwhile, surgeons must be cautious and selective before doing so.
- 15 March 2013
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 8 (1) , 46
Open AccessRight lower lobectomy eight years after left pneumonectomy for a second primary lung cancer
Lobectomy for second primary lung cancer in a patient with previous pneumonectomy is seldom done because most such patients either have inadequate pulmonary reserve or metastatic disease at other sites. This is different than when this type of surgery is done for benign disease where the lobe to be resected is already non functional. We report a case where successful right lower lobectomy for a second primary lung cancer was carried out in a 53 year old man who had had a left pneumonectomy eight years before. We conclude that, although this type of approach can be worthwhile, surgeons must be cautious and selective before doing so.
- Open Access
- 27 August 2012
- Published by Springer Nature in Diagnostic Pathology
- Vol. 7 (1) , 111
Apoptosis signal-regulating kinase 1 is associated with the effect of claudin-6 in breast cancer
Background: Previous studies have demonstrated that claudin-6 functions as a cancer suppressor in human MCF-7 breast cancer cells. The growth inhibitory effect could be attributed to inhibition of cell proliferation and induction of apoptosis. The purpose of the current study was to examine the involvement of apoptosis signal-regulating kinase 1 (ASK1) in the anticancer effect of claudin-6. Methods: Immunohistochemical analysis was performed to evaluate the ASK1 protein expression and the correlation between ASK1, claudin-6 and clinicopathological features in 85 samples of breast invasive ductal carcinomas (IDC). Western blotting and RT-PCR was carried out to examine the expression of ASK1 and claudin-6 in MCF-7 cell clones transfected with claudin-6. Results: Immunohistochemical analysis showed that ASK1 expression was significantly related with that of claudin-6 in breast invasive ductal carcinomas ( P < 0.05). In addition, a positive correlation between ASK1 and C-erb B 2 protein expression was identified ( P < 0.05). Western blotting and RT-PCR consistently revealed that the level of ASK1 protein and mRNA was upregulated in MCF-7 cell clones transfected with claudin-6. Conclusions: Our data suggests, for the first time, that the ASK1 signal may play a positive role in the inhibitory effect of claudin-6 in breast cancer. Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1200314318763661
- 27 August 2012
- Published by Springer Nature in Diagnostic Pathology
- Vol. 7 (1) , 111
Open AccessApoptosis signal-regulating kinase 1 is associated with the effect of claudin-6 in breast cancer
Background: Previous studies have demonstrated that claudin-6 functions as a cancer suppressor in human MCF-7 breast cancer cells. The growth inhibitory effect could be attributed to inhibition of cell proliferation and induction of apoptosis. The purpose of the current study was to examine the involvement of apoptosis signal-regulating kinase 1 (ASK1) in the anticancer effect of claudin-6. Methods: Immunohistochemical analysis was performed to evaluate the ASK1 protein expression and the correlation between ASK1, claudin-6 and clinicopathological features in 85 samples of breast invasive ductal carcinomas (IDC). Western blotting and RT-PCR was carried out to examine the expression of ASK1 and claudin-6 in MCF-7 cell clones transfected with claudin-6. Results: Immunohistochemical analysis showed that ASK1 expression was significantly related with that of claudin-6 in breast invasive ductal carcinomas ( P < 0.05). In addition, a positive correlation between ASK1 and C-erb B 2 protein expression was identified ( P < 0.05). Western blotting and RT-PCR consistently revealed that the level of ASK1 protein and mRNA was upregulated in MCF-7 cell clones transfected with claudin-6. Conclusions: Our data suggests, for the first time, that the ASK1 signal may play a positive role in the inhibitory effect of claudin-6 in breast cancer. Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1200314318763661